Palisade Bio
PALI
5 hedge funds and large institutions have $3.95M invested in Palisade Bio in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
17% less funds holding
Funds holding: 6 → 5 (-1)
35% less capital invested
Capital invested by funds: $6.08M → $3.95M (-$2.13M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$314K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.26M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.07M |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$354K |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$57K |
| 5 |
D.E. Shaw & Co
New York
|
-$28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CFA
51
CT Financial Advisors
Chadds Ford,
Pennsylvania
| $677 | – | – | – |
|
|
PI
52
Putnam Investments
Boston,
Massachusetts
| – | -$1.07M | -3 | Closed |
|
|
AFM
53
Anson Funds Management
Dallas,
Texas
| – | -$354K | -1 | Closed |
|
54
Citadel Advisors
Miami,
Florida
| – | -$3K | – | – |
|
|
55
D.E. Shaw & Co
New York
| – | -$28K | – | – |
|
56
LPL Financial
San Diego,
California
| – | -$27K | – | – |
|
|
57
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
| – | -$57K | – | – |
|
|
SBL
58
Sargent Bickham Lagudis
Boulder,
Colorado
| – | -$8K | – | – |
|
59
SG Americas Securities
New York
| – | -$3K | – | – |
|
|
VKH
60
Virtu KCG Holdings
New York
| – | -$4K | – | – |
|
PALI Hedge Fund Activity: Q3 2016 in Review
5 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2016, worth a combined $3.95M — down 35% from $6.08M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PALI and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $314K. The largest seller was Sabby Management, cutting an estimated $1.26M.
- 5 institutional investors held Palisade Bio (PALI) as of Q3 2016, down from 6 in Q2 2016.
- Funds reported $3.95M of Palisade Bio stock for Q3 2016, down 35% quarter-over-quarter.
- 1 fund opened new Palisade Bio positions in Q3 2016 and 2 closed out, a net change of -1 holder.
- The largest Palisade Bio buyer in Q3 2016 was Geode Capital Management, an estimated $314K added.
- The largest Palisade Bio seller in Q3 2016 was Sabby Management, an estimated $1.26M sold.
Based on aggregated 13F filings for Q3 2016.